Industry leaders from medical device and pharmaceutical sectors praised the government's revised taxation framework under the updated goods and services tax structure on Monday. Healthcare becomes more affordable through these changes, experts confirmed. The GST Council decreased levies on medical equipment from twelve percent to five percent earlier this month.
The Association of Indian Medical Device Industry described these modifications as groundbreaking for national healthcare independence. Most pharmaceutical products will face reduced taxation from twelve percent to five percent under the new system. Complete tax exemptions apply to thirty-six essential medications for cancer treatment, genetic disorders, rare conditions, and heart disease.
Additional reforms target health insurance premiums, blood glucose monitors, and vision correction glasses through rationalized tax categories. Sudarshan Jain from the Indian Pharmaceutical Alliance emphasized immediate patient savings through reduced financial burdens on families. These policy adjustments strengthen healthcare accessibility while improving medical security across the nation.
The Association of Indian Medical Device Industry described these modifications as groundbreaking for national healthcare independence. Most pharmaceutical products will face reduced taxation from twelve percent to five percent under the new system. Complete tax exemptions apply to thirty-six essential medications for cancer treatment, genetic disorders, rare conditions, and heart disease.
Additional reforms target health insurance premiums, blood glucose monitors, and vision correction glasses through rationalized tax categories. Sudarshan Jain from the Indian Pharmaceutical Alliance emphasized immediate patient savings through reduced financial burdens on families. These policy adjustments strengthen healthcare accessibility while improving medical security across the nation.
